A cold dread settled deep in Luna’s bones, solidifying with each tick of the ornate grandfather clock in Elias’s study. Her breath hitched, memories flashing behind her eyes. Every kind word, every reassuring pat on the shoulder from Marcus now felt like a viper’s coil, tightening, choking. He had introduced her to Elias. It wasn't a coincidence. It was a calculated, insidious move, a setup from the very beginning. Elias watched her, his expression a careful mask. He didn’t offer comfort. He didn’t need to. Her face, pale and drawn, spoke volumes. “Ready for the next layer?” he asked, his voice low, cutting through the heavy silence. Luna swallowed hard. Her throat felt raw. “There’s more?” “Always,” Elias affirmed, pushing a thick, leather-bound folder across the polished mahogany table. Its weight seemed to press down on the entire room. Opening the file, Luna saw pages filled with dense text, financial statements, and corporate logos. Her head swam. “Your father’s company, Thorne Industries,” Elias began, tapping a finger on a balance sheet. “It wasn’t just bad luck. Marcus systematically siphoned off assets, inflated debts, and manipulated stock prices through a network of shell corporations.” Tracing the lines of figures, Luna felt a chilling clarity. The complex web of transactions, the offshore accounts, the sudden shifts in market value – it all painted a picture of deliberate sabotage. Marcus hadn’t just failed to help; he had actively engineered their ruin. He had played the grieving brother, the supportive uncle, while gutting their legacy from the inside. Bitterness rose, sharp and acrid. Her hands trembled, clutching the documents. Every memory of her uncle’s supposed generosity, his financial advice, twisted into something grotesque. “This… this is proof,” she whispered, her voice barely audible. “Irrefutable.” Elias nodded, his gaze unwavering. “But it’s only half the story.” Pushing aside the initial set of documents, Elias retrieved another file, thinner but equally ominous. This one contained reports with medical jargon and clinical trial data. Luna’s eyes narrowed. “What is this?” “After your father’s death, Marcus didn’t just seize control of Thorne Industries’ remaining assets,” Elias explained. “He also diverted funds into a fledgling pharmaceutical venture. A risky, experimental one.” Experimental. The word echoed, cold and unsettling. Leo. Her brother’s fragile hope. His experimental treatment. “This company,” Elias continued, his voice precise, “specialized in neurological conditions. Specifically, rare, degenerative disorders that mirrored Leo’s illness.” A shiver traced its way down Luna’s spine. A coincidence? With Marcus, nothing was a coincidence. Not anymore. She picked up a report, scanning the abstract. It detailed a Phase II clinical trial for a new gene therapy. The dates, the patient profiles, the specific biomarkers… all disturbingly familiar. “Leo’s doctor, Dr. Aris,” Luna murmured, her mind racing. “He mentioned this type of therapy. He called it cutting-edge.” “Indeed,” Elias confirmed. “Dr. Aris is a respected name, but his research, and the facility where Leo receives treatment, are heavily funded by this particular pharmaceutical company. A company that Marcus Thorne has a significant, albeit hidden, financial interest in.” Hidden. That was Marcus’s specialty. Operating in the shadows, pulling strings, destroying lives from a distance. Luna felt a growing sense of horror. Was Leo’s treatment, his one shot at life, somehow tied to her uncle’s machinations? Was her brother a pawn in another one of Marcus’s twisted games? “Marcus used the remnants of Thorne Industries, and your family’s good name, to establish a network,” Elias stated, leaning forward slightly. “A network designed to funnel resources and obscure his true control over this new venture. He cultivated specific doctors, invested in specific research, all while keeping his name off the direct ownership papers.” Her uncle hadn’t just ruined her family’s past; he was actively manipulating their present, potentially gambling with Leo’s future. The cruelty was unfathomable. “This experimental treatment,” Luna started, her voice strained. “It’s… it’s his company, isn’t it? He’s profiting from Leo’s illness?” Elias simply slid a final document from the folder. It was a corporate registration form, listing major shareholders and board members of the pharmaceutical company. Luna’s eyes immediately fixated on a name, glaring back at her from the page. Thorne Biologics. Her uncle’s company. A direct connection to her brother’s dying hope, a poisoned gift masked as salvation.

Chapter 27: Pieces of a Poisoned Past